OMEROS CORP Other Current Assets
OMEROS CORP (OMER) had Other Current Assets of $99.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2015-11-09
- 2015-09-30: Other Assets, Current $99.00K.
- 2015-06-30: Other Assets, Current $108.00K.
- 2015-03-31: Other Assets, Current $116.00K.
- 2014-12-31: Other Assets, Current $120.00K.
| Period end | Other Assets, Current |
|---|---|
| 2015-09-30 | $99.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $108.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $116.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $120.00K 10-Q · filed 2015-11-09 |
| 2014-09-30 | $148.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $146.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $143.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $86.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |